|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -0.21% |
|
-.--% | +3.10% |
| 04-15 | Evotec Taps CureVac Executive as COO | MT |
| 01-06 | CureVac ends coverage after BioNTech acquisition |  |
| Market Cap | 867M 991M 800M 738M 1.4B 94.52B 1.42B 9.55B 3.75B 46.56B 3.72B 3.64B 160B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 424M 485M 391M 361M 686M 46.24B 697M 4.67B 1.84B 22.78B 1.82B 1.78B 78.31B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CureVac
| 1 day | -0.21% | ||
| Current year | +3.10% |
| Current year | 4.48 |  | 4.68 |
| 1 year | 4 | | 5.55 |
| 3 years | 2.22 | | 10.57 |
| 5 years | 2.22 | | 75.68 |
| 10 years | 2.22 | | 151.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 27/03/2023 | |
Myriam Mendila
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Malte Greune
COO | Chief Operating Officer | 61 | 30/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 31/07/2015 | |
Mathias Hothum
BRD | Director/Board Member | 58 | 31/07/2015 |
| Director/Board Member | 69 | 21/06/2022 |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -132M -151M -122M -113M -214M -14.44B -218M -1.46B -573M -7.11B -568M -556M -24.45B | - |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVAC Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
